Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population

114Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Cardiovascular disease is the main cause of morbidity and mortality among hemodialysis patients. Chronic renal failure influences a number of factors that cause accelerated atherogenesis, with calcium, phosphorus, and PTH playing key roles. Several studies have demonstrated the influence of these factors on all-cause and cardiovascular mortality in the American hemodialysis population. In the present study we evaluated the variables that influence long-term cardiovascular mortality in a European hemodialysis population. Methods. One hundred and forty-three hemodialysis patients were followed for six years. Several Cox models were used to study the influence of demographic and biochemical data, and comorbid conditions in cardiovascular survival, with a particular interest in mineral metabolism. Results. There was an increased risk of cardiovascular death in patients with serum P >6.5 mg/dL (risk ratio [RR], 2.5), PTH >50 pmol/L (RR, 3.9), Ca x P >52 (RR, 2.8), BB or Bb genotype (RR, 3.8), and in diabetics. Conclusion. There is a stronger influence of mineral metabolism on cardiovascular death among European patients when compared to the American population.

Cite

CITATION STYLE

APA

Marco, M. P., Craver, L., Betriu, A., Belart, M., Fibla, J., & Fernández, E. (2003). Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. In Kidney International, Supplement (Vol. 63). Blackwell Publishing Inc. https://doi.org/10.1046/j.1523-1755.63.s85.26.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free